OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • The OncLive Insider app is live!
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Novel Approaches to Treatment of Hepatocellular Carcinoma

home / news-network / novel-approaches-treatment-hcc
Understanding Biology and Patient Subsets in HCC

EP. 1: Understanding Biology and Patient Subsets in HCC

March 22nd 2019
Hepatocellular Carcinoma: Switching to Systemic Therapy

EP. 2: Hepatocellular Carcinoma: Switching to Systemic Therapy

March 22nd 2019
Frontline Therapy for HCC: Optimizing Treatment Selection

EP. 3: Frontline Therapy for HCC: Optimizing Treatment Selection

March 22nd 2019
Approaching Sequencing in HCC: Second-Line Therapy

EP. 4: Approaching Sequencing in HCC: Second-Line Therapy

March 22nd 2019
Sequencing Agents in HCC Based on Patient Subgroups

EP. 5: Sequencing Agents in HCC Based on Patient Subgroups

March 22nd 2019
Considering Adverse Events in Hepatocellular Carcinoma

EP. 6: Considering Adverse Events in Hepatocellular Carcinoma

March 22nd 2019
Ramucirumab's Role in Managing HCC

EP. 7: Ramucirumab's Role in Managing HCC

March 22nd 2019
Hepatocellular Carcinoma's Future Treatment Paradigm

EP. 8: Hepatocellular Carcinoma's Future Treatment Paradigm

March 22nd 2019

Latest Conference Coverage

First-Line Rucaparib Maintenance Reduces Progression Risk Across Prognostic Subgroups in HRD– High-Grade Ovarian Cancer

Raludotatug Deruxtecan Shows Activity in Platinum-Sensitive Ovarian Cancer

Relacorilant/Nab-Paclitaxel Is Associated With Survival Improvement in Platinum-Resistant Ovarian Cancer After Short Platinum-Free Interval

PD-L1 CPS Does Not Enrich the Efficacy of Atezolizumab/Bevacizumab and Chemo in Advanced Cervical Cancer

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact